San Diego, CA—KLATU Networks is proud to announce the award of our 8th U.S. patent, further securing our position as the industry leader in IoT-based predictive analytics for mission-critical storage systems in the life sciences and pharmaceutical sectors.
US Patent 11,829,929 titled "System-Independent Data Logging," a groundbreaking technology that transforms how temperature-sensitive materials are tracked and monitored throughout the shipping process.
The newly patented technology addresses a critical industry challenge: maintaining the integrity of temperature-stabilized commodities like pharmaceuticals, vaccines, tissue samples, cell lines, and specimens during transit. With over $800 million spent annually on clinical trials, the industry faces significant risk and cost due to improper shipment conditions. Our patented solution provides real-time data monitoring capabilities that significantly reduce these risks.
"The transport of temperature-stabilized commodities exposes shippers to risk, uncertainty, and high costs, particularly when international shipping is involved," said Rick Kriss, President of KLATU Networks. "Our system-independent data logging technology provides unprecedented visibility into shipment conditions, allowing for immediate intervention if temperature excursions occur."
The patented technology employs smart modules with data loggers attached to shipping containers, enabling continuous monitoring of environmental conditions including temperature, humidity, vibration, and shock. The system uniquely identifies each container and provides real-time information on the shipment's status, location, and condition throughout its journey.
This innovation builds upon KLATU's growing portfolio of patents in predictive failure analytics. By monitoring shipment conditions in real-time rather than retrospectively, companies can take corrective actions before valuable materials are compromised, potentially saving millions in product losses and preventing delays in critical research.
The technology is particularly valuable for clinical research organizations that traditionally over-allocate trial experiments by 5-10% to account for potential specimen degradation during shipping. KLATU's system helps eliminate this wasteful practice by ensuring temperature-sensitive materials remain within specification throughout transit.
For more information about KLATU Networks' patented technologies and how TRAXX can help your organization achieve near-zero breakdown performance, visit our website or contact our sales team.